Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ariel Polish"'
Autor:
B. T. Rhodes, Claudia Roxana Vintilescu, Lauren Nye, Ricardo Costa, Alfred Rademaker, Scott H. Okuno, Mohammed M. Milhem, B. C. Prunder, Steven I. Robinson, Rasima Cehic, Mark Agulnik, D. Daniels, Ariel Polish, Thomas McFarland, B.A. Van Tine, Keith M. Skubitz, Susan Abbinanti, Catherine Humphreys
Publikováno v:
Annals of Oncology. 28:121-127
Background Soft tissue sarcomas (STSs) overexpress vascular endothelial growth factors (VEGF) and VEGF-receptors (VEGFR) activation have been associated with tumor aggressiveness. Tivozanib is a potent small molecule tyrosine kinase inhibitor against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b85e5e07d4f57e0ce26a087fd5ace7
https://doi.org/10.1093/annonc/mdw444
https://doi.org/10.1093/annonc/mdw444
Publikováno v:
American journal of clinical oncology. 42(10)
Background Primary systemic therapy in resectable pancreatic cancer is currently under investigation. FOLFIRINOX has been shown to be effective in both the adjuvant and metastatic settings and is increasingly being used on and off study in the neoadj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64a467a8d51203c295ec7d38ca4ecaf
https://pubmed.ncbi.nlm.nih.gov/31569128
https://pubmed.ncbi.nlm.nih.gov/31569128
Publikováno v:
Journal of the National Comprehensive Cancer Network. 9:1397-1402
Neuroendocrine tumors (NETs) of unknown origin account for more than 10% of all NETs. Most of these tumors are poorly differentiated and, thus, very aggressive. Establishing the location of the primary tumor can be challenging. Workup of these NETs o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2edce53c3aef9fc4a3feb9da929690
https://doi.org/10.6004/jnccn.2011.0118
https://doi.org/10.6004/jnccn.2011.0118
Autor:
Mary F. Mulcahy, Ariel Polish
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 11(6)
Although T2,N0,M0 esophageal adenocarcinoma is grouped with other locoregional disease by NCCN, no consensus exists about how it should be treated. One of the inherent complexities of treating T2,N0,M0 esophageal adenocarcinoma is the inaccuracy of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb654a260f1ed0707109531bb19ec85
https://pubmed.ncbi.nlm.nih.gov/23744863
https://pubmed.ncbi.nlm.nih.gov/23744863
Autor:
Mark Agulnik, Mohammed M. Milhem, Alfred Rademaker, Catherine Humphreys, Susan E. Abbinanti, Lauren Elizabeth Nye, Rasima Cehic, Ariel Polish, Claudia Roxana Vintilescu, Thomas McFarland, Keith M. Skubitz, Steven Ian Robinson, Scott H. Okuno, Brian Andrew Van Tine
Publikováno v:
Journal of Clinical Oncology. 33:10515-10515
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b90ec4bc05bbdb50a3bd362711c5c43
https://doi.org/10.1200/jco.2015.33.15_suppl.10515
https://doi.org/10.1200/jco.2015.33.15_suppl.10515
Autor:
Mark Agulnik, Brian A. Van Tine, Keith M. Skubitz, Rasima Cehic, Catherine Humphreys, Susan Abbinanti, Alfred Rademaker, Steven I. Robinson, Lauren Nye, Ariel Polish, Scott H. Okuno, Mohammed M. Milhem, Thomas McFarland, Claudia Roxana Vintilescu
Publikováno v:
Journal of Clinical Oncology. 32:TPS10604-TPS10604
10515 Background: Despite a multi-modality approach, many patients (pts) with early stage soft tissue sarcomas (STS) will develop recurrent or metastatic disease. Treatment options for these pts ar...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::122a20e8751c35ec6776d65788e2c0fb
https://doi.org/10.1200/jco.2014.32.15_suppl.tps10604
https://doi.org/10.1200/jco.2014.32.15_suppl.tps10604